Compare PBH & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PBH | LMAT |
|---|---|---|
| Founded | 1996 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.6B |
| IPO Year | 2004 | 2006 |
| Metric | PBH | LMAT |
|---|---|---|
| Price | $55.21 | $111.99 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 5 |
| Target Price | $75.33 | ★ $105.80 |
| AVG Volume (30 Days) | ★ 490.0K | 132.7K |
| Earning Date | 05-08-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 0.93% |
| EPS Growth | 2.88 | ★ 30.57 |
| EPS | ★ 2.78 | 2.52 |
| Revenue | ★ $975,777,000.00 | $249,602,000.00 |
| Revenue This Year | N/A | $14.21 |
| Revenue Next Year | $4.31 | $8.88 |
| P/E Ratio | ★ $20.27 | $43.39 |
| Revenue Growth | ★ 36.77 | 13.53 |
| 52 Week Low | $51.24 | $78.01 |
| 52 Week High | $88.00 | $118.01 |
| Indicator | PBH | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 38.51 | 51.77 |
| Support Level | $51.24 | $82.24 |
| Resistance Level | $63.56 | $113.40 |
| Average True Range (ATR) | 1.84 | 3.53 |
| MACD | 0.09 | -0.78 |
| Stochastic Oscillator | 12.34 | 46.39 |
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.